Table 4.
Completeness of individual dimensions for selected data subsets
| Subset | Time to onset | Age | Indication | Outcome | Primary reporter | Sex | Report type | Country | Dose | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| Italy | 0.88 | 0.99 | 0.82 | 0.81 | 1.00 | 0.99 | 1.00 | 1.00 | 0.82 | 0.84 |
| Tunisia | 0.87 | 1.00 | 0.77 | 0.95 | 0.99 | 0.99 | 1.00 | 1.00 | 0.29 | 0.02 |
| Spain | 0.93 | 0.95 | 0.75 | 0.82 | 0.99 | 0.98 | 1.00 | 1.00 | 0.50 | 0.55 |
| INTDIS | 0.60 | 0.92 | 0.39 | 0.75 | 0.92 | 0.98 | 1.00 | 1.00 | 0.33 | 0.07 |
| E2B | 0.57 | 0.60 | 0.52 | 0.47 | 0.71 | 0.97 | 0.99 | 1.00 | 0.22 | 0.31 |
| VigiFlow | 0.71 | 0.95 | 0.48 | 0.75 | 0.93 | 0.97 | 1.00 | 1.00 | 0.45 | 0.80 |
| Consumer/non-health professional | 0.46 | 0.42 | 0.65 | 0.49 | 1.00 | 0.97 | 1.00 | 1.00 | 0.27 | 0.03 |
| Physician | 0.60 | 0.74 | 0.58 | 0.57 | 1.00 | 0.96 | 0.97 | 1.00 | 0.35 | 0.28 |
INTDIS International Drug Information System